WallStSmart

GE HealthCare Technologies Inc. (GEHC)vsLucid Diagnostics Inc (LUCD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

GE HealthCare Technologies Inc. generates 408529% more annual revenue ($20.98B vs $5.13M). GEHC leads profitability with a 9.1% profit margin vs 0.0%. GEHC earns a higher WallStSmart Score of 57/100 (C).

GEHC

Buy

57

out of 100

Grade: C

Growth: 4.0Profit: 6.0Value: 5.7Quality: 4.5
Piotroski: 2/9Altman Z: 1.34

LUCD

Avoid

29

out of 100

Grade: F

Growth: 8.0Profit: 2.5Value: 5.0Quality: 3.5
Piotroski: 4/9Altman Z: -12.94

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GEHC2 strengths · Avg: 8.0/10
P/E RatioValuation
15.6x8/10

Attractively priced relative to earnings

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

LUCD1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
51.7%10/10

Revenue surging 51.7% year-over-year

Areas to Watch

GEHC4 concerns · Avg: 2.8/10
PEG RatioValuation
1.844/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

EPS GrowthGrowth
-30.9%2/10

Earnings declined 30.9%

Altman Z-ScoreHealth
1.342/10

Distress zone — elevated risk

LUCD4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$187.53M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Return on EquityProfitability
-711.0%2/10

ROE of -711.0% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : GEHC

The strongest argument for GEHC centers on P/E Ratio, Price/Book.

Bull Case : LUCD

The strongest argument for LUCD centers on Revenue Growth. Revenue growth of 51.7% demonstrates continued momentum.

Bear Case : GEHC

The primary concerns for GEHC are PEG Ratio, Piotroski F-Score, EPS Growth.

Bear Case : LUCD

The primary concerns for LUCD are EPS Growth, Market Cap, Profit Margin. Debt-to-equity of 6.70 is elevated, increasing financial risk.

Key Dynamics to Monitor

GEHC profiles as a value stock while LUCD is a hypergrowth play — different risk/reward profiles.

LUCD carries more volatility with a beta of 1.08 — expect wider price swings.

LUCD is growing revenue faster at 51.7% — sustainability is the question.

GEHC generates stronger free cash flow (112M), providing more financial flexibility.

Bottom Line

GEHC scores higher overall (57/100 vs 29/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

GE HealthCare Technologies Inc.

HEALTHCARE · MEDICAL DEVICES · USA

GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.

Lucid Diagnostics Inc

HEALTHCARE · MEDICAL DEVICES · USA

Lucid Diagnostics Inc. is a commercial stage medical diagnostic technology company. The company is headquartered in New York, New York.

Visit Website →

Want to dig deeper into these stocks?